IRIS
STEFANINI, Giulio Giuseppe
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.456
AS - Asia 3.991
EU - Europa 1.616
SA - Sud America 1.341
AF - Africa 253
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 5
Totale 14.676
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.325
SG - Singapore 2.366
BR - Brasile 1.181
CN - Cina 880
FI - Finlandia 371
IE - Irlanda 272
VN - Vietnam 222
NG - Nigeria 177
DE - Germania 175
IT - Italia 161
SE - Svezia 116
HK - Hong Kong 112
FR - Francia 110
GB - Regno Unito 103
IN - India 103
NL - Olanda 90
AR - Argentina 63
CA - Canada 59
BD - Bangladesh 48
RU - Federazione Russa 46
TR - Turchia 46
MX - Messico 38
EC - Ecuador 30
ID - Indonesia 28
PL - Polonia 28
ES - Italia 27
JP - Giappone 27
IQ - Iraq 24
ZA - Sudafrica 23
UA - Ucraina 21
BE - Belgio 20
IL - Israele 16
MA - Marocco 15
VE - Venezuela 15
UZ - Uzbekistan 14
PE - Perù 13
GR - Grecia 11
PY - Paraguay 11
SA - Arabia Saudita 11
JM - Giamaica 10
PK - Pakistan 10
AE - Emirati Arabi Uniti 9
AU - Australia 9
JO - Giordania 9
AT - Austria 8
AZ - Azerbaigian 8
CL - Cile 8
CO - Colombia 8
KE - Kenya 8
LT - Lituania 8
UY - Uruguay 8
DZ - Algeria 7
TW - Taiwan 7
PT - Portogallo 6
RO - Romania 6
TH - Thailandia 6
A2 - ???statistics.table.value.countryCode.A2??? 5
CZ - Repubblica Ceca 5
EG - Egitto 5
OM - Oman 5
PH - Filippine 5
TN - Tunisia 5
AL - Albania 4
BO - Bolivia 4
CH - Svizzera 4
KZ - Kazakistan 4
NZ - Nuova Zelanda 4
SN - Senegal 4
CR - Costa Rica 3
CU - Cuba 3
GT - Guatemala 3
HN - Honduras 3
IR - Iran 3
KW - Kuwait 3
MY - Malesia 3
NO - Norvegia 3
NP - Nepal 3
PA - Panama 3
RS - Serbia 3
TT - Trinidad e Tobago 3
AO - Angola 2
BH - Bahrain 2
ET - Etiopia 2
HR - Croazia 2
KG - Kirghizistan 2
LA - Repubblica Popolare Democratica del Laos 2
LB - Libano 2
LU - Lussemburgo 2
MD - Moldavia 2
NI - Nicaragua 2
PS - Palestinian Territory 2
SK - Slovacchia (Repubblica Slovacca) 2
UG - Uganda 2
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
BS - Bahamas 1
Totale 14.656
Salva come PNG Salva come JPEG
Città #
Chandler 980
Wilmington 956
Singapore 822
The Dalles 592
Shanghai 523
Dallas 503
San Mateo 417
Ashburn 410
Helsinki 369
Boardman 271
Dublin 267
Ann Arbor 228
New York 222
Beijing 213
Lawrence 181
Princeton 181
Benin City 177
Leawood 147
São Paulo 106
Hong Kong 103
Ho Chi Minh City 98
Woodbridge 98
Los Angeles 96
Paris 92
Fairfield 90
Amsterdam 79
Pune 57
Milan 48
Hanoi 45
Seattle 44
London 37
Munich 36
Phoenix 30
Santa Clara 30
Brasília 27
Rio de Janeiro 27
Warsaw 27
Belo Horizonte 26
Council Bluffs 24
Curitiba 24
Kocaeli 24
Brooklyn 22
Tokyo 22
Chicago 21
Brussels 20
Montreal 20
Norwalk 20
San Diego 19
Toronto 18
Stockholm 17
Campinas 16
Cologno Monzese 16
Ribeirão Preto 16
San Francisco 16
Falkenstein 14
Mexico City 14
Dhaka 13
Guarulhos 13
Reston 13
Atlanta 12
Boston 12
Chennai 12
Moscow 12
Naples 12
Porto Alegre 12
Redmond 12
Baghdad 11
Denver 11
Guayaquil 11
Tashkent 11
Abbiategrasso 10
Johannesburg 10
Redwood City 10
Fortaleza 9
Houston 9
Orem 9
Quito 9
Assago 8
Baku 8
Columbus 8
Des Moines 8
Goiânia 8
Kingston 8
Lima 8
Salvador 8
São Gonçalo 8
São José do Rio Preto 8
Amman 7
Caxias do Sul 7
Haiphong 7
Manchester 7
Nairobi 7
New Delhi 7
Ninh Bình 7
Poplar 7
Santo André 7
São Bernardo do Campo 7
Ankara 6
Athens 6
Betim 6
Totale 9.399
Salva come PNG Salva come JPEG
Nome #
Additive effect of anemia and renal impairment on long-term outcome after percutaneous coronary intervention. 102
Monotherapy with a P2Y12 inhibitor or aspirin for secondary prevention in patients with established atherosclerosis: a systematic review and meta-analysis. 101
2014 ESC/EACTS Guidelines on myocardial revascularization. 99
2014 ESC/EACTS Guidelines on myocardial revascularization 96
Continuation versus discontinuation of ACE inhibitors or angiotensin II receptor blockers in COVID-19: Effects on blood pressure control and mortality 96
4-Year Clinical Outcomes and Predictors of Repeat Revascularization in Patients Treated With New Generation Drug-Eluting Stents in the RESOLUTE All Comers Randomized Trial. 95
2014 ESC/EACTS Guidelines on myocardial revascularization 95
2018 ESC/EACTS Guidelines on myocardial revascularization 95
How should I treat a DES restenosis in a graft anastomosis with challenging access and multiple previous coronary interventions? 94
Endovascular treatment vs. intravenous thrombolysis alone for ischaemic stroke: a meta-analysis of randomised controlled trials 94
Coral Reef Aorta: A Rare Occlusive Disease of the Aorta Complicating Decision Making for Severe Aortic Stenosis Treatment. 93
Direct oral anticoagulants in addition to antiplatelet therapy for secondary prevention after acute coronary syndromes: an updated systematic review and meta-analysis 92
Active surveillance for rheumatic heart disease in endemic regions: a systematic review and meta-analysis of prevalence among children and adolescents. 92
Early detection of elevated cardiac biomarkers to optimise risk stratification in patients with COVID-19 91
CAD in TAVI patients: relevance of disease complexity 89
2018 ESC/EACTS Guidelines on myocardial revascularization 88
2018 ESC/EACTS Guidelines on myocardial revascularization. 88
Does clinical data quality affect fluid-structure interaction simulations of patient-specific stenotic aortic valve models? 86
Fractional Flow Reserve-Guided Multivessel Angioplasty in Myocardial Infarction. 83
A new device for vascular embolization: report on case of two pulmonary arteriovenous fistulas embolization using the amplatzer vascular plug 83
Acute coronary syndrome in a patient with a residual aortic dissection flap after supracoronary aortic replacement: the role of intravascular ultrasound 83
Clinical and Technical Challenges of Prosthesis-Patient Mismatch After Transcatheter Aortic Valve Implantation 82
[Towards a standardized and minimalist future in interventional cardiology] 82
[Advances in the treatment of complex atherosclerotic disease: cracking the calcium and beyond] 82
What constitutes sufficient clinical evidence for stents? SpotLITE on the evaluation of novel coronary devices. 82
On the Modeling of Patient-Specific Transcatheter Aortic Valve Replacement: A Fluid–Structure Interaction Approach 82
A risk score based on baseline risk factors for predicting mortality in COVID-19 patients 82
Adverse events while awaiting myocardial revascularization: a systematic review and meta-analysis. 81
Cardioprotection with nebivolol in patients undergoing anthracyclines: a randomized placebo-controlled trial 80
Critical Organizational Issues for Cardiologists in the COVID-19 Outbreak: A Frontline Experience From Milan, Italy 78
An update on drug-eluting stents versus bare-metal stents in PCI treatment: are there any remaining indications for BMS use? 77
P2Y12 Inhibitors Monotherapy in Patients Undergoing Complex vs Non-Complex Percutaneous Coronary Intervention: A Meta-Analysis of Randomized Trials 75
Efficacy and Safety of Calcium Channel Blocker/Diuretics Combination Therapy in Hypertensive Patients: A Meta-Analysis. 75
Another reason to endorse and spread guidelines 75
Will LEADERS-FREE change my practice? A randomised double-blind comparison of the BioFreedom (TM) drug-coated stent vs. the Gazelle (TM) bare metal stent in patients at high bleeding risk using a short (1 month) course of dual antiplatelet therapy 74
Development and validation of a risk score using complete blood count to predict in-hospital mortality in COVID-19 patients 73
ST-Elevation Myocardial Infarction in Patients with COVID-19: Clinical and Angiographic Outcomes 72
Coronary stents: novel developments 71
Clinical outcomes of bioresorbable versus durable polymer-coated everolimus-eluting stents in real-world complex patients. 71
The association between in-stent neoatherosclerosis and native coronary artery disease progression: a long-term angiographic and optical coherence tomography cohort study 71
Clinical outcomes with reservoir-based polymer-free amphilimus-eluting stents in real-world patients according to diabetes mellitus and complexity: The INVESTIG8 registry. 71
Aspiration Thrombectomy for Treatment of ST-segment Elevation Myocardial Infarction: a Meta-analysis of 26 Randomized Trials in 11 943 Patients 71
The synergy stent in high-bleeding risk patients: why design matters 70
Impact of Diabetes on Clinical Outcomes After Polymer-Free Amphilimus- and Biolimus-Eluting Stent Implantation 70
Validation of the Valve Academic Research Consortium Bleeding Definition in Patients With Severe Aortic Stenosis Undergoing Transcatheter Aortic Valve Implantation 70
An individualized algorithm to predict mortality in COVID-19 pneumonia: a machine learning based study 69
Meta-Analysis of Randomized Controlled Trials of Percutaneous Coronary Intervention With Drug-Eluting Stents Versus Coronary Artery Bypass Grafting in Left Main Coronary Artery Disease. 69
What's new in the 2018 ESC/EACTS guidelines on myocardial revascularization? 69
Coronary Revascularisation in Transcatheter Aortic Valve Implantation Candidates: Why, Who, When? Interv Cardiol. 69
Percutaneous coronary interventional strategies for treatment of in-stent restenosis: a network meta-analysis 69
Safety and efficacy of drug-eluting stents in women: a patient-level pooled analysis of randomised trials. 69
Can Coronary Computed Tomography Angiography Replace Invasive Angiography? Coronary Computed Tomography Angiography Cannot Replace Invasive Angiography 68
New approach to direct stenting using a novel 'All-In-One' coronary stent system via 5 french diagnostic catheters: A pilot study 68
Is Transcatheter Aortic Valve Replacement Superior to Surgical Aortic Valve Replacement? A Meta-Analysis of Randomized Controlled Trials. 67
Transcatheter aortic valve implantation using the ACURATE neo in bicuspid and tricuspid aortic valve stenosis: a propensity-matched analysis of a European experience. 66
Coronary Artery Disease Severity and Aortic Stenosis: Clinical Outcomes According to SYNTAX-Score in Patients Undergoing Transcatheter Aortic Valve Implantation 66
Surgical or percutaneous revascularization for isolated left anterior descending stenoses: are we in the same boat? 65
Impact of Diabetes Mellitus in Women Undergoing Percutaneous Coronary Intervention with Drug-Eluting Stents: From the Women in Innovation and Drug-Eluting Stents Collaborative Patient-Level Pooled Analysis 65
Drug-Coated balloons vs drug-eluting stents for the treatment of small coronary artery disease: A meta-analysis of randomized trials 65
Balloon Versus Self-Expandable Valve for the Treatment of Bicuspid Aortic Valve Stenosis: Insights from the BEAT International Collaborative Registrys 65
Two-year clinical follow-up of the unrestricted use of the paclitaxel-eluting stent compared to the sirolimus-eluting stent as part of the Taxus-Stent Evaluated at Rotterdam Cardiology Hospital (T-SEARCH) registry 64
State of the art: coronary artery stents - past, present and future. 64
Association Between Colchicine Treatment and Clinical Outcomes in Patients with Coronary Artery Disease: Systematic Review and Meta-analysis 63
Oral Anticoagulant Type and Outcomes After Transcatheter Aortic Valve Replacement 63
Characterization of Myocardial Injury in Patients With COVID-19 63
Antiplatelet therapy for secondary prevention of cardiovascular disease: challenging the certainties 62
[Cardiac biomarkers in patients with COVID-19: pragmatic tools in hard times] 62
Myocardial revascularization appropriateness in Italy: Measuring the unmeasured 62
Long-term outcomes of biodegradable polymer versus durable polymer drug-eluting stents in patients with diabetes a pooled analysis of individual patient data from 3 randomized trials. 62
Management of ST-elevation myocardial infarction according to European and American guidelines. 62
Effects of Body Mass Index on Clinical Outcomes in Female Patients Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents: Results From a Patient-Level Pooled Analysis of Randomized Controlled Trials. 62
Predictors of Adverse Events Among Patient Undergoing Primary Percutaneous Coronary Intervention - Insights From a Pooled Analysis of the COMFORTABLE-AMI and EXAMINATION trials 62
Correlates and Impact of Coronary Artery Calcifications in Women Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents: From the Women in Innovation and Drug-Eluting Stents (WIN-DES) Collaboration 62
Evolving Routine Standards in Invasive Hemodynamic Assessment of Coronary Stenosis: The Nationwide Italian SICI-GISE Cross-Sectional ERIS Study. 62
The Valsalva maneuver in the diagnosis of patent foramen ovale. 61
Impact of sex on clinical and angiographic outcomes among patients undergoing revascularization with drug-eluting stents. 61
Safety and Efficacy of Resolute Zotarolimus-Eluting Stents Compared With Everolimus-Eluting Stents A Meta-Analysis 61
Clinical Outcomes and Revascularization Strategies in Patients With Low-Flow, Low-Gradient Severe Aortic Valve Stenosis According to the Assigned Treatment Modality 61
Duration of Dual Antiplatelet Therapy Following Drug-Eluting Stent Implantation in Diabetic and Non-Diabetic Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. 61
Left atrial appendage closure with the Ultraseal device: Initial experience and mid-term follow-up. 61
Clinical Application of Biomarkers in Heart Failure with a Preserved Ejection Fraction: A Review 61
Offline fusion of co-registered intravascular ultrasound and frequency domain optical coherence tomography images for the analysis of human atherosclerotic plaques. 61
Association of Hydroxychloroquine with QTc Interval in Patients with COVID-19 61
Distal vs Conventional Radial Access for Coronary Angiography and/or Intervention: A Meta-Analysis of Randomized Trials 60
Role of Niacin in current clinical practice: A systematic review 60
The impact of patient and lesion complexity on clinical and angiographic outcomes after revascularization with zotarolimus- and everolimus-eluting stents: a substudy of the RESOLUTE All Comers Trial 60
Stent performance: never too late to sort it out. 60
Are the culprit lesions severely stenotic? 59
Long-Term Survival Following Multivessel Revascularization in Patients With Diabetes: The FREEDOM Follow-On Study 59
Effect of Chronic Kidney Disease in Women Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents A Patient-Level Pooled Analysis of Randomized Controlled Trials 59
Severe aortic stenosis and coronary artery disease. 59
The Contemporary Pulse of Bioresorbable-Scaffold Thrombosis Among Expert Operators 58
Safety and efficacy of polymer-free biolimus-eluting stents in all-comer patients: the RUDI-FREE study. 58
Report of an ESC-EAPCI Task Force on the evaluation and use of bioresorbable scaffolds for percutaneous coronary intervention: executive summary. 58
Algorithm for Individual Prediction of COVID-19-Related Hospitalization Based on Symptoms: Development and Implementation Study 58
Drug-Eluting Coronary Artery Stents 57
Myocardial ischemia and coronary disease in heart failure. 57
Early Doppler-echocardiography evaluation of 597 prosthetic aortic valves. 57
Safety of Prasugrel Loading Doses in Patients Pre-Loaded With Clopidogrel in the Setting of Primary Percutaneous Coronary Intervention Results of a Nonrandomized Observational Study 57
New-Generation Drug-Eluting Stents for Left Main In-Stent Restenosis: The DELTA-2 Registry. 57
Totale 7.178
Salva come PNG Salva come JPEG
Categoria #
all - tutte 114.081
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 114.081
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.776 0 0 0 0 0 494 338 135 381 240 2 186
2021/2022902 24 9 16 245 6 2 21 148 73 68 246 44
2022/20232.885 421 110 236 313 315 206 13 213 514 287 197 60
2023/20242.132 222 151 406 128 105 275 153 128 20 49 196 299
2024/20253.368 45 32 43 32 60 351 281 330 478 837 416 463
2025/20263.946 1.377 683 500 871 313 202 0 0 0 0 0 0
Totale 15.049